期刊文献+

槲皮素诱导下乳腺癌细胞对三苯氧胺耐药的增敏效应 被引量:6

Quercetin-induced strengthening efficiency to Tamoxifen in Tamoxifen-resistance breast cancer cells
下载PDF
导出
摘要 目的探讨槲皮素对逆转乳腺癌细胞内分泌耐药的应用价值。方法选用雌激素受体阳性的人乳腺癌细胞株MCF-7,高浓度短时间冲击法建立三苯氧胺(tamoxifen,TAM)耐药细胞株(MCF-7Ca/TAM-R)。根据槲皮素给药浓度将实验组MCF-7Ca/TAM-R细胞分为实验1组(10μmol/L)、实验2组(25μmol/L)和实验3组(50μmol/L),各浓度组再分成2个亚组:槲皮素+OHT(4-hydroxytamoxifen,4-OH-TAM)同时干预组、槲皮素干预12 h后加入OHT序贯干预组;阴性对照组加入OHT;空白对照组不加任何药物。噻唑蓝法(MTT)检测各组细胞的增殖抑制率,流式细胞术检测各组细胞的凋亡。结果高浓度短时间冲击法成功建立人乳腺癌三苯氧胺耐药细胞株。各实验组细胞均有不同程度的增殖抑制和凋亡(P=0.000),该效应随槲皮素诱导剂量的递增而增强(P=0.000);低剂量(10μmol/L)用药对耐药细胞的增殖和凋亡无显著影响(P>0.05和P>0.002),槲皮素和三苯氧胺同时或序贯给药差异亦无统计学意义(P>0.05和P>0.002)。结论在槲皮素诱导下,三苯氧胺对耐药细胞的增殖抑制和凋亡效应随槲皮素诱导剂量的增加而增强,提示槲皮素可能具有逆转乳腺癌细胞对三苯氧胺的耐药性,该效应与槲皮素和三苯氧胺同时或序贯给药无关。 [Objective] To explore the value of Quercetin in reversal resistance to endocrine in breast cancer cells. [Methods] The impact- method of high concentration and short-term to MCF- 7, the human breast cancer cell line with estrogen receptor-position were used to establish Tamoxifen-resistant cell strain (MCF- 7Ca/TAM- R). According to the concentration of Quercetin, experimental group MCF- 7Ca/TAM-R cells were divided into experimental group 1 (10 Ixmol/L), experimental group 2 (25umol/L) and group 3 (50 umol/L). Each concentration group was further divided into two subgroups: Quereetin + OHT (4- hydroxy Ta- moxifen, 4- OH- TAM) simul-administrating group and sequential intervening group with Quercetin inducing 12 hours followed by the OHT. Negative control group was addded OHT and blank control group without any drugs. Proliferative inhibitory rate of each group cells were detected by MTT and apoptotic rate by Flow Cy- tometry. [Results] Tamoxifen-resistant cells line of breast cancer had been established successfully with the impact- method of high concentration and short-term. All of the experimental group cells appeared prolifera- tive inhibition and apoptosis in different degrees (P =0.000). These effects were enhanced with gradual in- creasing of induced dose of Quercetin (P=0.000). Proliferative inhibition and apoptosis in low- dose (10 umol/ L) of Quercetin had no significant difference (P 〉0.05 and P 〉0.002). The differences between simultaneous and sequential administration of Quercetin and Tamoxifen was no significant yet (P 〉0.05 and P 〉0.002).[Conclusion] Under Quercetin induced, efficiency of proliferative inhibition and apoptosis of Tamoxifen- re- sistance cell were enhanced with gradually increasing dose of Quereetin. This result supports the presumplion that Quercetin was provided with reversal effect in Tamoxifen- resistance of breast cancer cells. This reversal effect is independent without administrative mode of simultaneity or sequence of Quercetin and Tamoxifen.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第5期39-44,共6页 China Journal of Modern Medicine
基金 广东省深圳市科技计划资助项目(No:201103316)
关键词 槲皮素 乳腺癌 三苯氧胺耐药 内分泌治疗 Quercetin breast cancer Tamoxifen-resistance endocrine therapy
  • 相关文献

参考文献4

二级参考文献30

  • 1吕蔡,张杰.128槲皮素的药理作用[J].国外医药(植物药分册),2005,20(3):108-112. 被引量:36
  • 2Coser K R, Wittner B S, Rosenthal N F, et al. Antiestrogen-resistant subclones of MCF-7 human breast cancer ceils are derived from a com- mon monoclonal drug-resistant progenitor[ Jl. Proc Natl Acad Sci U S A, 2009, 106(34) : 14536 - 14541.
  • 3Jordan V C. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer : the origins of targeted ther- apy and ehemoprevention [ Jl. Cancer Res, 2009, 69 (4) : 1243 - 1254.
  • 4Criscitiello C, Fumagalli D, Saini K S, et al. Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection [ J ]. Onco Targets Ther, 2010, 4:1 -11.
  • 5Fan P, Wang J, Santen R J, et al. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer ceils [ J l- Cancer Res, 2007, 67(3) : 1352 - 1360.
  • 6Powles T J, Ashley S, Tidy A, et al. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial[ J ]. J Natl Cancer Inst, 2007, 99 (4) : 283 -290.
  • 7Hackshaw A, Roughton M, Forsyth S, et al. Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer[ J]. J Clin On- col, 2011,29(13) : 1657 -1663.
  • 8Hodges-Gallagher L, Valentine C D, EI-Bader S, et al. Estrogen re- ceptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells [ J ]. Breast Cancer Res Treat, 2008, 109(2) : 241 -250.
  • 9Ong CS, Tran E, Nguyen TT, et al. Quercet in-induced growth inhibition and cell death in nasopharyngeal carcinom a cells are associated with increase in Bad and hypophosphorylated retinob lastom a expressions [J].Oncol Rep,200d, 11 (3):727-733.
  • 10Zhang W, Konopleva M, Ruvolo VR, et al. Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway[J].Leukemia, 2008, 22(4):808-818.

共引文献30

同被引文献119

  • 1金子林,郭锡熔,周旭华,周炯英,倪毓辉,王玢,潘晓勤,陈荣华.MAPK8基因在小鼠源性3T3-L1脂肪细胞诱导分化中表达水平的变化[J].中国儿童保健杂志,2004,12(4):327-329. 被引量:9
  • 2徐咏梅,杨国旺,王笑民,韩冬,于洁,赵文硕.丹栀逍遥散加减治疗乳腺癌内分泌综合征65例临床观察[J].河北中医,2005,27(9):676-676. 被引量:19
  • 3罗玲,吴凯南.槲皮素对乳腺癌细胞MDA-MB-435S抑制作用及其机制[J].重庆医学,2005,34(12):1774-1776. 被引量:2
  • 4陈灏珠,林果为,王吉耀实用内科学[M].14版北京:人民卫生出版社:2013:9.
  • 5Cho SY, Kim MK, Park KS, et al. Quercetin-POC conju- gates: Differential stability and bioaetivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines[J]. Bioorg Med Chem, 2013, 21(7): 1671-1679.
  • 6Duo J, Ying GG, Wang GW, et al. Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation[J]. Mol Med Rep, 2012, 5 (6): 1453- 1456.
  • 7Deng XH, Song HY, Zhou YF, etal. Effects of quercetin on the proliferation of breast cancer cells and expression of sur- vivin in vitro[J]. Exp Ther Med, 2013, 6(5) . 1155-1158.
  • 8Mense SM, Chhabra J, Bhat HK. Preferential induction of ey- toehrome P450 1A1 over eytoehrome P4501B1 in human breast epithelial cells following exposure to quereetin[J]. Journal of Steroid Biochemistry and Molecular Biology, 2008, 110 (1/2) : 157-162.
  • 9Sotoca AM, Ratman D, Van Der Saag P, et al. Phytoestro- gen-mediated inhibition oi' proliferation of the human T47D breast cancer cells depends on the ER alpha/ER beta ratio[J]. J Ster Biochem Mol Biol, 2008, 112(4/5). 171-178.
  • 10Resende FA, De Oliveira AP, De Camargo MS, etal. Evalua- tion of estrogenic potential of flavonoids using a recombinant yeast strain and MCFT/BUS cell proliferation assay[J]. PLoS One, 2013, 8(10): e74881.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部